Community Acquired Pneumonia clinical trials

Explore recruiting community acquired pneumonia clinical trials.

Recruiting community acquired pneumonia studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Community Acquired Pneumonia trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Local Antibiotic Delivery for Community Acquired Pneumonia (LANDCAP 2)

Denmark

Therapeutic exploratory (Phase II) EU CTIS Study details

An Exploratory, Multi-Centre, Interventional, Prospective, Randomised, Double-Blind, Placebo-Controlled Clinical Trial to Assess the Safety and Efficacy of AON-D21 in Patients with Severe Community-Acquired Pneumonia.

Belgium, France, Germany, Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

The Norwegian Antibiotics for Pneumonia in Children (NAPIC) Study

Norway

Therapeutic use (Phase IV) EU CTIS Study details

CUSTOMIZED ANTIBIOTIC TREATMENT DURATION AMONG HOSPITALIZED PATIENTS WITH MODERATELY SEVERE COMMUNITY-ACQUIRED PNEUMONIA [CAT-CAP]

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Randomized, Embedded, Multifactorial Adaptive Platform trial for Community-Acquired Pneumonia

France, Romania, Portugal, Italy, Belgium, Germany +7 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Local Antibiotic Delivery for Community Acquired Pneumonia - Pilot study (LANDCAP1)

Denmark

Therapeutic exploratory (Phase II) EU CTIS Study details

Community Acquired Pneumonia trials by city

Community Acquired Pneumonia in Toronto Community Acquired Pneumonia in Vancouver Community Acquired Pneumonia in Montreal Community Acquired Pneumonia in Calgary Community Acquired Pneumonia in Edmonton Community Acquired Pneumonia in Ottawa Community Acquired Pneumonia in Winnipeg Community Acquired Pneumonia in Quebec City Community Acquired Pneumonia in Hamilton Community Acquired Pneumonia in Kitchener Community Acquired Pneumonia in London Community Acquired Pneumonia in Halifax Community Acquired Pneumonia in New York Community Acquired Pneumonia in Los Angeles Community Acquired Pneumonia in Chicago Community Acquired Pneumonia in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease